FDA Approves New Drug for Locally Advanced Skin Cancer (FREE)

By Kristin J. Kelley Edited by Susan Sadoughi, MD Sonidegib (brand name: Odomzo) has been approved for the treatment of locally advanced basal cell carcinoma. It is indicated for adults …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news